CRESS | $234,000 | (Feb 21, 2025)
Safe Intelligence | $5,253,443 | (Feb 21, 2025)
Reverb Therapeutics | $21,000,000 | (Feb 21, 2025)
Acclinate
United States
- Birmingham, AL
- 08/05/2024
- Series A
- $17,000,000
Our vision is health equity through inclusive research. We help pharmaceutical companies and healthcare organizations access and engage communities of color so research is more inclusive.
- Industry Biotechnology
- Website https://www.acclinate.com/
- LinkedIn https://www.linkedin.com/company/acclinateinc/
Related People
Del Smith, PhDFounder
United States -
Birmingham, Alabama
Dr. Del Smith uses his diverse background in healthcare, IT, higher education, and business to drive greater healthcare equity. He is the CEO and Cofounder of Acclinate, a company using sustained community engagement and AI to mobilize historically marginalized communities for greater equity in healthcare.
Prior to cofounding Acclinate, Del dedicated nearly fifteen years to higher education as a business professor and then Dean of a business school. His research on success factors of minority-owned businesses has been published in journals such as the Journal of Business Research and the Journal of Developmental Entrepreneurship.
Del is a U.S. Army veteran and holds a Ph.D. in Business from the University of Alabama.
QuSecure | $28,000,000 | (Feb 21, 2025)
AheadComputing | $21,500,000 | (Feb 21, 2025)
Together AI | $30,000,000 | (Feb 21, 2025)
Kodesage | $2,300,000 | (Feb 21, 2025)
OpenEvidence | Undisclosed Amount | (Feb 21, 2025)
Oso Semiconductor | $5,200,000 | (Feb 21, 2025)
EnPlusOne Biosciences | $10,000,000 | (Feb 21, 2025)
Pinkfish | $7,600,000 | (Feb 21, 2025)
Esperto Medical | Undisclosed Amount | (Feb 21, 2025)